πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 56 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7413754

Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases

Bionorica AG Β· Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368534

Myostatin and mimetics thereof

ORICO LIMITED Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6635672

Agent for lowering prolactin

Bionorica AG Β· Granted Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6306444

Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated

BIONORICA ARZNEIMITTEL GMBH Β· Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6238671

Process for the gentle recovery of extract fractions from hypericum, pharmaceutical prepar

BIONORICA ARZNEIMITTEL GMBH Β· Granted Tue May 29 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6117430

Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated

BIONORICA ARZNEIMITTEL GMBH Β· Granted Tue Sep 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6068816

Process for the mild reduction of germs in pharmaceutical preparations

BIONORICA ARZNEIMITTEL GMBH Β· Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6045789

Bystander effect tumoricidal therapy by expressing an HSV-tk gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired